Xia Yuan Selected Research

LC28 compound

9/2018

Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xia Yuan Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 01/2012
6	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2016
6	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 09/2017
6	Inflammation (Inflammations) 03/2023 - 11/2019
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
4	Breast Neoplasms (Breast Cancer) 03/2021 - 01/2012
3	Microsatellite Instability 01/2024 - 01/2021
3	Carcinogenesis 10/2023 - 03/2021
3	Necrosis 01/2022 - 11/2019
2	Body Weight (Weight, Body) 10/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2023
2	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 10/2023 - 03/2017
2	Disease Progression 09/2023 - 01/2021
2	Fibrosis (Cirrhosis) 03/2023 - 06/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
2	Nasopharyngeal Carcinoma 01/2021 - 06/2017
2	Prostatic Neoplasms (Prostate Cancer) 04/2020 - 01/2020
2	Dermatomyositis (Dermatopolymyositis) 01/2020 - 08/2018
2	Stomach Neoplasms (Stomach Cancer) 11/2018 - 04/2013
2	Ovarian Neoplasms (Ovarian Cancer) 09/2018 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 04/2011
2	Parkinson Disease (Parkinson's Disease) 01/2016 - 04/2011
1	Stroke (Strokes) 04/2024
1	Carcinoma (Carcinomatosis) 04/2024
1	Heart Failure 02/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2023
1	Brain Ischemia (Cerebral Ischemia) 03/2023
1	Bites and Stings (Sting) 01/2023
1	Hemorrhage 01/2023
1	Lung Injury 01/2023
1	Pancreatitis 01/2023
1	Glioma (Gliomas) 09/2022
1	Anhedonia 02/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2018
3	Circular RNAIBA 05/2023 - 03/2021
3	Mitochondrial DNA (mtDNA)IBA 01/2023 - 01/2020
3	Bevacizumab (Avastin)FDA Link 04/2022 - 01/2021
3	Long Noncoding RNAIBA 01/2022 - 09/2017
3	MicroRNAs (MicroRNA)IBA 11/2018 - 10/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 10/2023
2	Carcinoembryonic AntigenIBA 01/2024 - 04/2022
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2023 - 01/2023
2	Competitive Endogenous RNAIBA 10/2023 - 09/2017
2	Capecitabine (Xeloda)FDA Link 09/2023 - 04/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2021
2	Carbon Tetrachloride (Tetrachloromethane)IBA 09/2022 - 06/2015
2	CarbonIBA 01/2022 - 11/2019
2	Cathepsin BIBA 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 09/2018
2	ProdrugsIBA 04/2020 - 01/2016
2	EsterasesIBA 04/2020 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 11/2019
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 11/2019
2	Cisplatin (Platino)FDA LinkGeneric 09/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 09/2018 - 04/2013
2	Messenger RNA (mRNA)IBA 08/2018 - 06/2015
2	Proteasome InhibitorsIBA 01/2017 - 01/2016
2	bufalinIBA 06/2016 - 01/2016
1	Frizzled ReceptorsIBA 04/2024
1	Cytochromes c (Cytochrome c)IBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023
1	alpha2 Subunit Collagen Type IIBA 10/2023
1	Collagen Type I (Type I Collagen)IBA 10/2023
1	Cetuximab (Erbitux)FDA Link 09/2023
1	ginsenoside Rg1IBA 03/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2023
1	Therapeutic UsesIBA 03/2023
1	SialyltransferasesIBA 02/2023
1	PolymersIBA 02/2023
1	Warfarin (Coumadin)FDA LinkGeneric 01/2023
1	semaglutideIBA 01/2023
1	Trypan Blue FDA Link 09/2022
1	octadecadienoic acidIBA 09/2022
1	SolventsIBA 09/2022
1	Caspase 9IBA 09/2022
1	Fluorouracil (Carac)FDA LinkGeneric 09/2022
1	EnzymesIBA 09/2022
1	ImmunosorbentsIBA 09/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 09/2022
1	AcidsIBA 09/2022
1	Sucrose (Saccharose)IBA 02/2022
1	B7-H1 AntigenIBA 01/2022
1	camrelizumabIBA 01/2022

Therapy/Procedure

11	Therapeutics 10/2023 - 01/2015
7	Drug Therapy (Chemotherapy) 04/2024 - 01/2012
2	Immunotherapy 01/2022 - 01/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 06/2017
2	Oral Administration 05/2019 - 05/2012
1	Postoperative Care 02/2024
1	Heart-Assist Devices 02/2024